Next |
home / stock / ocup / ocup message board
Subject | By | Source | When |
---|---|---|---|
skip | Dr_Vonschellan | investorshub | 11/29/2022 7:28:47 PM |
$OCUP CompanyOverview | conix | investorshub | 11/23/2022 4:10:05 PM |
If it wasn't for the election stuff, this | KOmani | investorshub | 11/08/2022 4:00:21 PM |
Analysts calling for 24-26$ target | PennyPusher786 | investorshub | 11/08/2022 3:19:40 PM |
This may just rise all day with that | PennyPusher786 | investorshub | 11/08/2022 3:03:10 PM |
Nice news but seems someone is shorting everything. | KOmani | investorshub | 11/08/2022 1:26:45 PM |
Still waiting for this to favorably turn | batski | investorshub | 05/13/2022 9:38:44 PM |
I guess today's news wasn't good enough :( | bcapps66 | investorshub | 03/29/2022 3:08:28 PM |
Yes I'm waiting even if it takes another | batski | investorshub | 02/18/2022 10:41:38 PM |
At this point, seems best to wait for | bcapps66 | investorshub | 01/27/2022 5:52:50 PM |
amen | batski | investorshub | 01/24/2022 3:21:39 PM |
My heart is breaking on this one :'( | bcapps66 | investorshub | 01/24/2022 2:45:39 PM |
These red days are getting rather annoying | bcapps66 | investorshub | 12/01/2021 3:02:26 PM |
And the bleeding continues :( | bcapps66 | investorshub | 11/30/2021 5:32:16 PM |
Took some call options today looking good for | Chad088 | investorshub | 11/27/2021 2:42:53 AM |
Too late to run....I'm a long term holder now | bcapps66 | investorshub | 11/24/2021 11:58:43 PM |
Aholes are making $ by letting shorts short | 420man | investorshub | 11/24/2021 11:15:22 PM |
I'm an official bagholder | bcapps66 | investorshub | 11/24/2021 10:57:42 PM |
I can literally see the CEO and cohorts | 420man | investorshub | 11/24/2021 10:04:54 PM |
DILUTION POS's selling into good news.. SO sad! | 420man | investorshub | 11/24/2021 9:08:21 PM |
News, Short Squeeze, Breakout and More Instantly...
Ocuphire Pharma Inc Com Company Name:
OCUP Stock Symbol:
NASDAQ Market:
FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced financial r...
FARMINGTON HILLS, Mich., May 06, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that clinical data...
FARMINGTON HILLS, Mich., May 03, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that George Magrath, M.D. M.B.A., M.S., Chief...